يعرض 1 - 20 نتائج من 688 نتيجة بحث عن '"Wohlleben, Wolfgang"', وقت الاستعلام: 1.32s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المساهمون: Microbial Natural Products, Department of Food and Nutrition, Cyanobacteria research

    وصف الملف: application/pdf

    Relation: This work was supported by the ERA-IB project MESIAB (EIB 10.004). KH van Pee, L Flor, J Ludwig-Muller and L Jahn were funded by the Sachsische Staatsministerium fur Wissenschaft und Kunst (SMWK) and the Sachsische Aufbaubank (SAB). W Wohlleben and T Schafhauser were funded by the Bundesministerium fur Bildung und Forschung (BMBF, grant 0315934). T Weber is supported by a grant of the Novo Nordisk Foundation. MME Huijbers and WJH van Berkel were supported by grants from the Netherlands Organisation for Scientific Research (NWO) and The Graduate School VLAG (Wageningen, The Netherlands). D Fewer and K Sivonen were funded by Finnish Funding Agency for Technology and Innovation (TEKES 40007/11). We gratefully acknowledge the revision of the phylogenetic trees by Dr. A Yurkov (DSMZ, Braunschweig, Germany) as well as Drs. Robert Lucking (Botanischer Garten und Botanisches Museum Berlin, Germany) and Peter Johnston (Landcare Research, New Zealand) for their expert assistance in revision.; Jahn , L , Schafhauser , T , Pan , S , Weber , T , Wohlleben , W , Fewer , D , Sivonen , K , Flor , L , van Pée , K-H , Caradec , T , Jacques , P , Huijbers , M M E , van Berkel , W J H & Ludwig-Müller , J 2017 , ' Cyanodermella asteris sp. nov. ( Ostropales ) from the inflorescence axis of Aster tataricus ' , Mycotaxon , vol. 132 , no. 1 , pp. 107-123 . https://doi.org/10.5248/132.107; ORCID: /0000-0003-3978-4845/work/40493866; ORCID: /0000-0002-2904-0458/work/40494107; http://hdl.handle.net/10138/566672; 767e275c-93ab-49fd-8d80-8e68fd93faa3; 85022074588; 000401891900013

  4. 4
    Academic Journal
  5. 5
    Periodical
  6. 6
    Academic Journal

    المؤلفون: MITOUSIS, LENA, WOHLLEBEN, WOLFGANG

    المصدر: Biologie in unserer Zeit; 2024 Special Issue, Vol. 54, p13-17, 5p

  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
  17. 17
    Academic Journal

    المساهمون: Helmholtz-Zentrum für Infektionsforschung GmbH (HZI), Universität des Saarlandes Saarbrücken = Saarland University Saarbrücken, German Centre for Infection Research (DZIF), Università degli studi di Parma = University of Parma (UNIPR), Danmarks Tekniske Universitet = Technical University of Denmark (DTU), Justus-Liebig-Universität Gießen = Justus Liebig University (JLU), Chimie biologique épigénétique - Epigenetic Chemical Biology (EpiCBio), Institut Pasteur Paris (IP)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Écologie et Évolution de la Résistance aux Antibiotiques / Ecology and Evolution of Antibiotics Resistance (EERA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Saclay-Université Paris Cité (UPCité)-Microbiologie Intégrative et Moléculaire (UMR6047), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS)-Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS), Dynamique des Génomes et Adaptation Microbienne (DynAMic), Université de Lorraine (UL)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Goethe-Universität Frankfurt am Main, Max Planck Institute for Terrestrial Microbiology, Max-Planck-Gesellschaft, Universidade de Lisboa = University of Lisbon = Université de Lisbonne (ULISBOA), Molécules de Communication et Adaptation des Micro-organismes (MCAM), Muséum national d'Histoire naturelle (MNHN)-Centre National de la Recherche Scientifique (CNRS), Wageningen University and Research Wageningen (WUR), Institut de Biologie Intégrative de la Cellule (I2BC), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), Fundación MEDINA Granada, John Innes Centre Norwich, Biotechnology and Biological Sciences Research Council (BBSRC), Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), University of Manchester Manchester, Università degli Studi di Perugia = University of Perugia (UNIPG), Eberhard Karls Universität Tübingen = University of Tübingen, Institut de Chimie de Strasbourg (IC), Université de Strasbourg (UNISTRA)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS), Jacobs University = Constructor University Bremen, University Hospital Bonn, Biophys Usk, UK, University of Bristol Bristol, Recursion Salt Lake City, UT, HiberCell New York, Uppsala Universitet Uppsala, AMR Insights, University of Ljubljana, BEAM Alliance, Naicons, Drugs for Neglected Diseases Initiative, Global Antibiotic Research and Development Partnership Geneva, Switzerland (GARDP), University of Dundee, Novartis Institutes for BioMedical Research (NIBR), The project on PqsR pathoblocker development acknowledges funding through the German Center for Infection Research (DZIF, projects TTU09.908 and TTU09.916), the Helmholtz Association (Helmholtz Validation Fund) and additional contributions by the associated academic institutes (HZI and HIPS). The development of chelocardins is supported by the DZIF (TTU09.814/09.821), the Helmholtz Innovation Fund (Pre-4D), by the Slovenian Research Agency, ARRS, grant no. J4-8226, and in collaboration with AciesBio, Slovenia. The corallopyronin project is funded by the DZIF (TTU09.807/09.816, TTU09.914), the German Federal Ministry of Education and Research (BMBF), the federal state of North Rhine-Westphalia (EFRE.NRW) and EU Horizon 2020. Eriko Takano was funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 720793 “TOPCAPI: Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients”., European Project: 720793,H2020-EU.2.1.4.,TOPCAPI(2017)

    المصدر: ISSN: 2397-3358.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34426795; info:eu-repo/grantAgreement//720793/EU/Thoroughly Optimised Production Chassis for Advanced Pharmaceutical Ingredients/TOPCAPI; PUBMED: 34426795; PUBMEDCENTRAL: PMC8374425; WOS: 000686482900001

  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal